N. TURAN YÜCEL Et Al. , "Catecholaminergic and opioidergic system mediated effects of reboxetine on diabetic neuropathic pain," PSYCHOPHARMACOLOGY , vol.237, no.4, pp.1131-1145, 2020
TURAN YÜCEL, N. Et Al. 2020. Catecholaminergic and opioidergic system mediated effects of reboxetine on diabetic neuropathic pain. PSYCHOPHARMACOLOGY , vol.237, no.4 , 1131-1145.
TURAN YÜCEL, N., CAN, Ö. D., & DEMİR ÖZKAY, Ü., (2020). Catecholaminergic and opioidergic system mediated effects of reboxetine on diabetic neuropathic pain. PSYCHOPHARMACOLOGY , vol.237, no.4, 1131-1145.
TURAN YÜCEL, NAZLI, ÖZGÜR DEVRİM CAN, And ÜMİDE DEMİR ÖZKAY. "Catecholaminergic and opioidergic system mediated effects of reboxetine on diabetic neuropathic pain," PSYCHOPHARMACOLOGY , vol.237, no.4, 1131-1145, 2020
TURAN YÜCEL, NAZLI T. Et Al. "Catecholaminergic and opioidergic system mediated effects of reboxetine on diabetic neuropathic pain." PSYCHOPHARMACOLOGY , vol.237, no.4, pp.1131-1145, 2020
TURAN YÜCEL, N. CAN, Ö. D. And DEMİR ÖZKAY, Ü. (2020) . "Catecholaminergic and opioidergic system mediated effects of reboxetine on diabetic neuropathic pain." PSYCHOPHARMACOLOGY , vol.237, no.4, pp.1131-1145.
@article{article, author={NAZLI TURAN YÜCEL Et Al. }, title={Catecholaminergic and opioidergic system mediated effects of reboxetine on diabetic neuropathic pain}, journal={PSYCHOPHARMACOLOGY}, year=2020, pages={1131-1145} }